Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in thioaptamer development.

Xianbin Yang1, David G Gorenstein

  • 1Sealy Center for Structural Biology and Department of Human Biological Chemistry & Genetics, The University of Texas Medical Branch, Galveston, Texas 77555-1157, USA.

Current Drug Targets
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic insights into three Bacillus strains for biocontrol of tobacco black shank disease.

International microbiology : the official journal of the Spanish Society for Microbiology·2026
Same author

Development and Characterization of CD44-Targeted X-Aptamers with Enhanced Binding Affinity for Cancer Therapeutics.

Bioengineering (Basel, Switzerland)·2025
Same author

Synthesis of Nucleotides Bearing the 2'-O-Trifluoromethyl Group and Their Application in RNA Analogs Preparation.

Current protocols·2024
Same author

A Convenient Method for the Synthesis of 2'-O-Cyanoethylated Nucleotides and Their Application in the Solid-Phase Synthesis of Related RNA Analogs.

Current protocols·2023
Same author

First Report of Meloidogyne arenaria Infecting Maize in Guizhou Province of China.

Plant disease·2023
Same author

Remaining useful life and state of health prediction for lithium batteries based on differential thermal voltammetry and a deep learning model.

iScience·2022
Same journal

Extracellular Vesicles from Mesenchymal Stem Cells Alleviate Spinal Cord Injury via the miR-486-5p/PTEN/PI3K/AKT Pathway.

Current drug targets·2026
Same journal

Improving B-cell Linear Epitope Prediction <i>via</i> Multiple Feature Fusion and an Integrated Machine Learning Algorithm.

Current drug targets·2026
Same journal

Mechanistic Insights into the Inhibition of Plasmodium falciparum DNA Gyrase A by Withanolide Derivatives through Integrated Computational Analysis.

Current drug targets·2026
Same journal

Epitranscriptomics in Breast Cancer: The Unveiled Role of RNA Modifications.

Current drug targets·2026
Same journal

Neuroinflammation in Alzheimer's Disease: New Approaches.

Current drug targets·2026
Same journal

FXYD3: A Key Regulator of Ion Homeostasis and Redox Balance in Cancer Biology.

Current drug targets·2026
See all related articles

Thioaptamers, modified nucleic acids, offer superior affinity, specificity, and stability compared to traditional aptamers. New selection methods yield thioaptamers that can modulate protein activity in vivo.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oligonucleotide Chemistry

Background:

  • Traditional aptamers, while useful, have limitations in stability and affinity.
  • Nucleic acid modifications can enhance aptamer properties.
  • Thiophosphate modifications offer unique advantages due to sulfur backbone integration.

Purpose of the Study:

  • To outline an in vitro thioaptamer selection procedure for optimized backbone modifications.
  • To describe a novel bead-based selection protocol for diverse thioaptamer backbones.
  • To demonstrate the application of thioaptamers in modulating protein activity.

Main Methods:

  • In vitro selection for sequence and hybrid phosphoromonothioate/phosphate backbones.
  • Bead-based selection for mixed phosphorodithioate, phosphoromonothioate, or phosphate backbones.

Related Experiment Videos

  • In vivo assays to assess protein activity modulation by selected thioaptamers.

    • Main Results:

    • Development of efficient in vitro and bead-based thioaptamer selection protocols.
    • Successful isolation of thioaptamers with enhanced affinity, specificity, and stability.
    • Demonstration of thioaptamers' ability to modulate target protein activity in vivo.

    Conclusions:

    • Thioaptamers represent a significant advancement over traditional aptamers.
    • The described selection methods provide versatile tools for thioaptamer development.
    • Thioaptamers hold promise for therapeutic applications targeting protein activity.